Search hospitals > Texas > Houston
Baylor College of Medicine
Claim this profileHouston, Texas 77030
Global Leader in Breast Cancer
Global Leader in Syndrome
Conducts research for Fibrosis
Conducts research for Flu
Conducts research for Human Immunodeficiency Virus Infection
1378 reported clinical trials
110 medical researchers
Summary
Baylor College of Medicine is a medical facility located in Houston, Texas. This center is recognized for care of Breast Cancer, Syndrome, Fibrosis, Flu, Human Immunodeficiency Virus Infection and other specialties. Baylor College of Medicine is involved with conducting 1,378 clinical trials across 1,213 conditions. There are 110 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mohamed O. Othman, MD, and Mothaffar Rimawi, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 positive
2Syndrome
Global LeaderMELAS
MT-TK
POLG
Top PIs
Jennifer Foster, MDBaylor College of Medicine/Dan L Duncan Comprehensive Cancer Center2 years of reported clinical research
Expert in Tumors
Expert in Neuroblastoma
33 reported clinical trials
49 drugs studied
Patricia Baxter, MDTexas Children's Hospital2 years of reported clinical research
Expert in Brain Tumor
Expert in Diffuse Intrinsic Pontine Glioma
32 reported clinical trials
40 drugs studied
Mohamed O. Othman, MDBaylor College of Medicine3 years of reported clinical research
Studies Gastrointestinal Tumors
Studies Digestive System Tumors
17 reported clinical trials
27 drugs studied
Mothaffar Rimawi, MDBaylor College of Medicine5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
10 reported clinical trials
22 drugs studied
Clinical Trials running at Baylor College of Medicine
Breast Cancer
Crohn's Disease
Depression
Pancreatic Cancer
Ulcerative Colitis
Epilepsy
Chronic Obstructive Pulmonary Disease
Hepatocellular Carcinoma
Liver Cancer
Cardiomyopathy
Delayed SLND Tracing
for Breast Cancer
The trial aims to investigate the use of superparamagnetic iron oxide (SPIO) nanoparticles as a tracer for delayed sentinel lymph node dissection (d-SLND) in patients where upfront axillary surgery (SLND) is oncologically deemed unnecessary and should be avoided. This includes but is not limited to patients with a preoperative diagnosis of ductal cancer in situ of the breast (DCIS), an unclear BIRADS 4-5 planned for diagnostic excision or women planned for risk reducing mastectomy. SPIO is injected in the primary operation, and should final specimen pathology demonstrate invasive breast cancer, only then is an operation in the axilla (d-SLND) performed.
Recruiting2 awards Phase 39 criteria
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Baylor College of Medicine?
Baylor College of Medicine is a medical facility located in Houston, Texas. This center is recognized for care of Breast Cancer, Syndrome, Fibrosis, Flu, Human Immunodeficiency Virus Infection and other specialties. Baylor College of Medicine is involved with conducting 1,378 clinical trials across 1,213 conditions. There are 110 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mohamed O. Othman, MD, and Mothaffar Rimawi, MD.
Where is Baylor College of Medicine located?
Baylor College of Medicine is located in the Texas Medical Center at 6651 Main St, Houston, TX, offering easy access via major freeways and thoroughfares.
Who should I call to ask about financial aid or insurance network?
For general inquiries at Baylor College of Medicine, please call (713) 798-4951. For financial assistance or billing concerns, contact the Baylor Scott & White Health Financial Assistance Program at 1-800-725-0024 (North Texas) or 1-800-994-0371 (Central Texas). The Baylor College of Medicine Billing Office is available at (713) 798-1900 for billing questions.
What insurance does Baylor College of Medicine accept?
The Baylor College of Medicine accepts a variety of insurance plans, including HMO, PPO, and POS managed care programs. Baylor Scott & White Health facilities accept Traditional Medicaid, Traditional Medicare, and any Medicare Supplement/Medigap plan, along with being contracted providers for insurance companies like Aetna, Blue Cross Blue Shield, Cigna, Humana, and more. Always verify coverage with the hospital or health plan before scheduling a visit or procedure.
What awards or recognition has Baylor College of Medicine received?
Baylor College of Medicine has been awarded a $14.85 million grant for neurological research and $24 million for cancer research and prevention. Additionally, they provide collaborative pilot grants in partnership with the University of Houston and have received awards funded by the DeBakey Medical Foundation.